Ledger.Open graph →
SEC Form D · filed May 8, 2025

TriSalus Life Sciences, Inc

Offering
$22.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WESTMINSTER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jens O. Hollermann · Luxembourg, LuxembourgDirectorMurad Beg · Chagrin Falls, OHDirectorL. Davies · London, United KingdomExecKevin Duffy · San Francisco, CADirectorR. Gibbs · San Diego, CAExecMichael Falotico · Randolph, MADirectorTait A. Duryea · Reno, NVExec · DirectorNathan T. Sims · Grapevine, TXExecKevin Daly · Kentfield, CADirectorY. Shimizu · Singapore, U0DirectorJames Young · Columbus, INExecGary F. Gordon · Westminster, CODirectorBrian F. Cox · Westminster, COExecWilliam F. Valle · Westminster, CODirectorJames Young · Vancouver, British Columbia, CanadaExecGary F. Gordon · Westminster, CODirectorBrian F. Cox · Westminster, COExecWilliam F. Valle · Westminster, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗